Number of the records: 1  

Engineered Delivery of Dental Stem-Cell-Derived Extracellular Vesicles for Periodontal Tissue Regeneration

  1. 1.
    SYSNO ASEP0558806
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleEngineered Delivery of Dental Stem-Cell-Derived Extracellular Vesicles for Periodontal Tissue Regeneration
    Author(s) Zárubová, Jana (FGU-C) RID, ORCID
    Hasani-Sadrabadi, M. M. (US)
    Dashtimoghadam, E. (US)
    Zhang, X. (US)
    Ansari, S. (US)
    Li, S. (US)
    Moshaverinia, A. (US)
    Number of authors7
    Article number2102593
    Source TitleAdvanced Healthcare Materials. - : Wiley - ISSN 2192-2640
    Roč. 11, č. 12 (2022)
    Number of pages10 s.
    Languageeng - English
    CountryGB - United Kingdom
    Keywordsextracellular vesicles ; immunoengineering ; local drug delivery ; periodontal tissue healing ; periodontitis
    OECD categoryDentistry, oral surgery and medicine
    Method of publishingLimited access
    Institutional supportFGU-C - RVO:67985823
    UT WOS000764955700001
    EID SCOPUS85125564359
    DOI10.1002/adhm.202102593
    AnnotationPeriodontal disease begins as an inflammatory response to a bacterial biofilm deposited around the teeth, which over time leads to the destruction of tooth-supporting structures and consequently tooth loss. Conventional treatment strategies show limited efficacy in promoting regeneration of damaged periodontal tissues. Here, a delivery platform is developed for small extracellular vesicles (sEVs) derived from gingival mesenchymal stem cells (GMSCs) to treat periodontitis. EVs can achieve comparable therapeutic effects to their cells of origin. However, the short half-lives of EVs after their administration along with their rapid diffusion away from the delivery site necessitate frequent administration to achieve therapeutic benefits. To address these issues, “dual delivery” microparticles are engineered enabling microenvironment-sensitive release of EVs by metalloproteinases at the affected site along with antibiotics to suppress bacterial biofilm growth. GMSC sEVs are able to decrease the secretion of pro-inflammatory cytokines by monocytes/macrophages and T cells, suppress T-cell activation, and induce the formation of T regulatory cells (Tregs) in vitro and in a rat model of periodontal disease. One-time administration of immunomodulatory GMSC sEV-decorated microparticles leads to a significant improvement in regeneration of the damaged periodontal tissue. This approach will have potential clinical applications in the regeneration of a variety of tissues.
    WorkplaceInstitute of Physiology
    ContactLucie Trajhanová, lucie.trajhanova@fgu.cas.cz, Tel.: 241 062 400
    Year of Publishing2023
    Electronic addresshttps://doi.org/10.1002/adhm.202102593
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.